NLRP1 inflammasome, and not NLRP3, is the key in the shift to proinflammatory state on endothelial cells in peripheral arterial disease

International Journal of Cardiology

Volumn 172, Issue 2, 2014, Pages

  Bleda, Silvia ^a   De Haro, Joaquin ^a   Varela, Cesar ^a   Esparza, Leticia ^a   Ferruelo, Antonio ^a   Acin, Francisco ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

Atherosclerosis; Endothelium; Inflammasomes; Inflammation; Peripheral vascular disease

Indexed keywords

CRYOPYRIN; INFLAMMASOME; NLRP1 PROTEIN; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; AUTACOID; BIOLOGICAL MARKER; CARRIER PROTEIN; NLRP1 PROTEIN, HUMAN; NLRP3 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

AGE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FEMALE; FLOW ARTERIAL MEDIATED DILATION; GENDER; GENE; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; HUMAN; HUMAN AORTIC ENDOTHELIAL CELL; HUMAN ARTERIAL ENDOTHELIAL CELL; HUMAN CELL; IMMUNOPATHOGENESIS; INFLAMMATION; INNATE IMMUNITY; LETTER; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NLRP1 GENE; NLRP3 GENE; ONSET AGE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; VASCULAR ENDOTHELIAL CELL; BLOOD; CELL CULTURE; METABOLISM; PATHOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS REGULATORY PROTEINS; BIOLOGICAL MARKERS; CARRIER PROTEINS; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; HUMANS; INFLAMMASOMES; INFLAMMATION MEDIATORS; MALE; PERIPHERAL ARTERIAL DISEASE;

EID: 84900644337     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.12.201     Document Type: Article

References (10)

1. F. Martinon, A. Mayor, and J. Tschopp The inflammasomes: guardians of the body Annu Rev Immunol 27 2009 229 265
2. P. Duewell, H. Kono, and K.J. Rayner et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals Nature 464 2010 1357 1361
3. K. Rajamäki, J. Lappalainen, and K. Oörni et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation PLoS One 5 2010 e11765
4. J. Tschopp, and K. Schroder NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 10 2010 210 215
5. D.A. Muruve, V. Pétrilli, and A.K. Zaiss et al. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response Nature 452 2008 103 107
6. P. Menu, M. Pellegrin, and J.F. Aubert et al. Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome Cell Death Dis 2 2011 e137
7. F. Martinon, K. Burns, and J. Tschopp The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta Mol Cell 10 2002 417 426
8. A. Florez, J. de Haro, E. Martínez, C. Varela, S. Bleda, and F. Acín Selective cyclooxygenase-2 inhibition reduces endothelial dysfunction and improves inflammatory status in patients with intermittent claudication Rev Esp Cardiol 62 2009 851 857
9. C. Varela, J. de Haro, S. Bleda, L. Esparza, I.L. de Maturana, and F. Acin Anti-endothelial cell antibodies are associated with peripheral arterial disease and markers of endothelial dysfunction and inflammation Interact Cardiovasc Thorac Surg 13 2011 463 467
10. L. Zitvogel, O. Kepp, L. Galluzzi, and G. Kroemer Inflammasomes in carcinogenesis and anticancer immune responses Nat Immunol 13 2012 343 351